Icosavax has a total of 229 patents globally, out of which 5 have been granted. Of these 229 patents, more than 90% patents are active. United States of America is where Icosavax has filed the maximum number of patents, followed by China and Singapore. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Icosavax.
Icosavax founded in 2017, Icosavax was a biotechnology company focused on developing vaccines for serious infectious diseases, including respiratory syncytial virus (RSV). Its VLP platform used computationally designed virus-like particles to display complex viral antigens and potentially generate broad, durable immune protection. The company was acquired by AstraZeneca.
Do read about some of the most popular patents of Icosavax which have been covered by us in this article and also you can find Icosavax patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Icosavax patent portfolio.
How many patents does Icosavax have?
Icosavax has a total of 229 patents globally. These patents belong to 15 unique patent families. Out of 229 patents, 208 patents are active.
How Many Patents did Icosavax File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Icosavax Applications Filed | Icosavax Patents Granted |
| 2026 | 3 | 3 |
| 2025 | 33 | 1 |
| 2024 | 70 | – |
| 2023 | 56 | 1 |
| 2022 | 33 | – |
| 2021 | 34 | – |
How many Icosavax patents are Alive/Dead?
Worldwide Patents
How Many Patents did Icosavax File in Different Countries?
Countries in which Icosavax Filed Patents
| Country | Patents |
| United States of America | 15 |
| China | 13 |
| Singapore | 13 |
| Europe (EPO) | 12 |
| Canada | 12 |
| Korea (South) | 11 |
| Australia | 11 |
| Mexico | 11 |
| Japan | 10 |
| Israel | 9 |
| Hong Kong (S.A.R.) | 8 |
| Indonesia | 8 |
| India | 8 |
| Philippines | 7 |
| New Zealand | 7 |
| South Africa | 7 |
| Viet Nam | 6 |
| Costa Rica | 6 |
| Colombia | 6 |
| Eurasia | 6 |
| Argentina | 6 |
| Taiwan | 6 |
| Brazil | 6 |
| Chile | 5 |
| Russia | 3 |
| Morocco | 1 |
| Peru | 1 |
| Malaysia | 1 |
Where are Research Centres of Icosavax Patents Located?
10 Best Icosavax Patents
WO2021252688A1 is the most popular patent in the Icosavax portfolio. It has received 11 citations.
Below is the list of 10 most cited patents of Icosavax:
| Publication Number | Citation Count |
| WO2021252688A1 | 11 |
| WO2022103967A1 | 5 |
| CN117202928A | 3 |
| CN121568951A | 2 |
| CN119836300A | 2 |
| WO2024238311A1 | 2 |
| WO2022260960A1 | 2 |
| US20250222092A1 | 1 |
| US20240252621A1 | 1 |
| US20230227790A1 | 1 |
What Percentage of Icosavax US Patent Applications were Granted?
Icosavax (Excluding its subsidiaries) has filed 6 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Icosavax patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Icosavax?
| Law Firm | Total Applications | Success Rate |
| Mintz Levin | 6 | 100.00% |
What are Icosavax key innovation segments?
What Technologies are Covered by Icosavax?
The chart below distributes patents filed by Icosavax